NYSE · Healthcare · Medical Distribution · USA
Mckesson Corp is a large cap company (market value between $10 billion and $200 billion) in the Medical Distribution industry.
McKesson Corporation distributes branded, generic, specialty, and over-the-counter pharmaceutical drugs to pharmacies, hospitals, and healthcare providers across North America. The company operates four business divisions: pharmaceutical distribution, oncology services, prescription technology, and medical-surgical supplies, serving biopharma companies, care providers, pharmacies, manufacturers, and governments.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Mckesson Corp stock.
Fairly valued: intrinsic value $1001.81 per share, market price $1010.43, margin of safety -0.9% (as of 2026-10-19).
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $1,001.81; the price of $1,010.43 is 1% above that value, and 82% of that value comes from beyond year five.
Leak Score: 58/100 on 10 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 11 Medical Distribution stocks
MCK is fairly valued (as of the 2026-10-19 close). Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $1,001.81; the price of $1,010.43 is 1% above that value, and 82% of that value comes from beyond year five.
$1001.81 per share (as of the 2026-10-19 close), against a market price of $1010.43. That is a margin of safety of -0.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for roughly the growth the company has already delivered. No miracle needed, no discount either. Yearly sales growth the price needs: 12.0%. Yearly sales growth it has sustained: 11.7%.
58 out of 100, which we rate "Weak Signal", on 10 of 12 value investing signals.